Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (1261-1270 of 1,434) with videos related to

Pageof 144
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology|February 14, 2018
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesMatthew R Cooperberg, James D Brooks, Anna V Faino, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
European Urology|July 6, 2012
Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus PanelFrancesco Montorsi, Timothy G Wilson, Raymond C Rosen, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
JCO Precision Oncology|July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion SequencingEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialWolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Pageof 144

Showing results (1261-1270 of 1,434) with videos related to

Sort By:
Pageof 144
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology|February 14, 2018
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesMatthew R Cooperberg, James D Brooks, Anna V Faino, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
European Urology|July 6, 2012
Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus PanelFrancesco Montorsi, Timothy G Wilson, Raymond C Rosen, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
JCO Precision Oncology|July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion SequencingEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialWolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Pageof 144